Charities criticise NICE breast cancer drug ruling
Breast cancer charities have expressed their “utter disappointment” after the health regulator said a new drug to treat breast cancer was ”not value for money”.
Get unlimited access
As a subscriber you will benefit from:
- Full online and mobile access to news and opinion stories
- Customised email alerts straight to your inbox (30+ alerts available)
- 4,500 practice articles in our archive
- Over £500 worth of CPD learning units